Regulatory Science 606:

Regulation of Emerging Technologies and Biological Products (3.0 units)

Policies, testing and regulatory requirements affecting commercialization of biologics and novel medical technologies. Focus on biologics, blood and tissue products, radiopharmaceuticals and nanotechnology
    49141D626LectureTBATBA19 of 50Eunjoo Pacifici,Frances Richmond,
    Susan Bain,
    Nancy Pire-Smerkanich
    OFFICE & ONLINEsession dates
    Information accurate as of March 10, 2022 2:00 pm.
    Did you find what you needed today? Let us know by taking a short survey.